Advent Therapeutics
2014
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
$300K
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of therapies for micro-orphan applications. The company develops a prenatal, neonatal and pediatric drug for orphans to cure disorder in newborn infants in the intensive care unit (ICU).
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
- 6500 Old Carversville Road
- Lumberville, PA 18933
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Advent Therapeutics’s full profile, request a free trial.
Advent Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 12-Sep-2016 | $300K | 00000 | Completed | Product Development | |
| 2. Seed Round | 19-Aug-2015 | 00000 | 00000 | Completed | Product Development | |
| 1. Seed Round | 11-Dec-2014 | Completed | Product Development |
Advent Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Ben Franklin Technology Partner of Southeastern Pennsylvania | Venture Capital | Minority | 000 0000 | 000000 0 |